A gold nanostar-based SERS platform for point-of-care diagnostics of carbapenemase-producing enterobacteriacae

Wei Cherng Malvin Kang; Yen Lynn Wong; Marek Piotrowski; Woon Pei Jeanette Teo; Shuai He; James Chen-Yong Kah

doi:10.1117/12.2269911

29 April 2017 A gold nanostar-based SERS platform for point-of-care diagnostics of carbapenemase-producing enterobacteriacae

Wei Cherng Malvin Kang, Yen Lynn Wong, Marek Piotrowski, Woon Pei Jeanette Teo, Shuai He, James Chen-Yong Kah

Author Affiliations +

Proceedings Volume 10340, International Conference on Biophotonics V; 1034011 (2017) https://doi.org/10.1117/12.2269911
Event: International Conference on Biophotonics V, 2017, Perth, Australia

Abstract

The ever-increasing spread and emergence of antibiotic resistance poses a serious threat to global public health. With the existence of Carbapenem-resistant Enterobacteriaceae (CRE) produced by the Klebsiella Pneumoniae bacteria, it renders the use of carbapenems, the last-resort class of β-lactam antibiotics, useless against combating against bacterial infections. Such infections reduce the ability to treat complex infections due to the lack of antibiotic options for treatment, leading to CRE-associated mortalities. Current methods of detection, like CarbaNP test and Modified Hodge’s Test, have significant limitations in that the time taken for detection of carbapenemase activity ranges between hours to days, and are non-specific in detecting the specific phenotype, making it challenging to isolate patients rapidly and to devise appropriate treatment for infected patients. We propose a methodology by utilising Surface Enhanced Raman Spectroscopy (SERS) to study bacterial β-lactamase activity. This is done via the use of gold nanostars (AuNS), which have reported excellent SERS properties, conjugated with a β-lactam antibiotic ceftriaxole, as a proof-of-concept study to analyse the changes in the SERS spectra associated with cleavage of the β-lactam ring upon interaction with the New Delhi Metalloproteinase (NDM)- producing Escherichia coli (Class B β-lactamase). We are able to obtain detection of carbapenemase activity within 25 minutes, with the associated changes in SERS spectra being diminishing of SERS peaks at 1358cm^-1 and 1495cm^-1. This project can be further extended to study the activity of other classes of β-lactamases and other β-lactam antibiotics to improve this state of technology for potential adoption by healthcare institutions.

Citation Download Citation

Wei Cherng Malvin Kang, Yen Lynn Wong, Marek Piotrowski, Woon Pei Jeanette Teo, Shuai He, and James Chen-Yong Kah "A gold nanostar-based SERS platform for point-of-care diagnostics of carbapenemase-producing enterobacteriacae", Proc. SPIE 10340, International Conference on Biophotonics V, 1034011 (29 April 2017); https://doi.org/10.1117/12.2269911

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available